Yorkville Advisors

Yorkville Advisors is a New Jersey-based alternative investment manager that specializes in providing specialty financing solutions. The firm focuses on flexible debt and equity investments in publicly listed companies across various sectors, including healthcare, mining, oil and gas, real estate, manufacturing, shipping, and technology. Yorkville tailors its financial transactions to meet the specific needs of each investment, which may involve bridge financings, asset-backed notes, equity facilities, and direct equity participation. Founded in 2001, Yorkville employs a combination of technical and fundamental analysis to guide its investment strategies, seeking opportunities in public equity, fixed income, and alternative investment markets worldwide. The firm also has additional offices in Florida, Colorado, Italy, and Hong Kong.

James Carr

VP of Corporate Finance and Research

Anthony Chan

MD and Head of Asia

Wayne Coy

SVP of Corporate Finance

Amir Elbaz

SVP of Special Situations

Lester D. Garrett

Senior Managing Director & Head of Energy

Saad Gilani

Managing Director

Michael Holland

SVP of Corporate Finance

Samuel Jimenez

VP of Corporate Finance

Michael J. Nowak

MD and Head of Healthcare

Troy J. Rillo

Senior Managing Director

Edward Schinik

CFO and COO

Michael Schreck

SVP and Head of Special Situations Group

Paul Strzelecki

MD

79 past transactions

Canoo

Post in 2022
Canoo is a Los Angeles-based company that has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that defies traditional ownership to put customers first. Distinguished by its experienced team – totaling over 350 employees from leading technology and automotive companies – Canoo has designed a modular electric platform purpose-built to deliver maximum vehicle interior space and adaptable to support a wide range of vehicle applications for consumers and businesses. For more information, please visit www.canoo.com. For Canoo press materials, including photos, please visit press.canoo.com. For investors, please visit investors.canoo.com.

Galaxy Next Generation

Private Placement in 2019
Galaxy Next Generation, “G2,” is proud to be a leader in bringing forth the technology for the Classroom of Today. They are NOT just another Technology Provider! They are working hand-in-hand with educators to help them evolve teaching and learning in their Connected Classrooms. This new approach leverages digital content, learning data, and one-of-a-kind technologies in order to create an immersive and interactive experience. The opportunity being presented to “G2” is one where they can empower teachers with a new way to motivate and engage students in learning activities.

SciSparc

Private Placement in 2018
We are a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, we have initiated two internal drug development programs based on repurposing a U.S. Food and Drug Administration, or FDA, approved synthetic cannabinoid (dronabinol): Joint Pharma develops THX-TS01 targeted to the treatment of Tourette Syndrome, or TS, and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of mild cognitive impairments, or MCIs.

Romeo Power

Post in 2022
Romeo Power, Inc., an energy technology company, focuses on designing and manufacturing lithium-ion battery modules and packs for commercial electric vehicles. It enables sustainable transportation by delivering batteries with shorter charge times. The company’s modules include Hermes modules for trucks and buses; and Brown Recluse, a passive cooling system designed to maximize heat transfer coefficient and integrate into various vehicle types and system configurations across voltage and capacity ranges. Romeo Power, Inc. is headquartered in Vernon, California.
MobileMax (TASE: MBMX) is connecting Finance to technology. Savings from better technology and improved management can be captured and monitored for max profits and reduced risks. The technology provided by Mobile Max and its financial infrastructure provided by Mobile Max Capital, Mobile Max Insurance and Mobile Max Commodities and Logistics, allows Mobile Max to provide clients with the best funding, longest terms and lowest risk for projects that are structured with proven technologies and guaranteed efficiency savings.

Lordstown Motors

Post in 2021
Lordstown Motors Corporation is an American automobile manufacturer of electric vehicles.Lordstown Motors is completing the engineering and development of the first full-electric pickup truck.

MICT, Inc. (NasdaqCM:MICT)

Private Placement in 2018
MICT, Inc. designs, develops, manufactures, and sells rugged mobile computing and video telematics devices. Its products comprise tablets, on-board-computers, and dash cams that provide fleet operators and field workforces with computing solutions for various work environments, such as extreme temperatures, repeated vibrations, or dirty and wet or dusty conditions. The company’s portable tablets enhance workforce productivity by offering computing power and communication capabilities that provide fleet operators with visibility into vehicle location, fuel usage, speed, and mileage; and manage the drivers in various aspects, such as driver identification and behavior, reporting hours worked, customer/organization working procedures and protocols, route management and navigation based on tasks and time schedule. It also provides SmartHub, which offers consumers with services, such as driver recognition, identifying and preventing driver fatigue, recognizing driver behavior, preventive maintenance, fuel efficiency, and a driver assistance system; and a platform to offer services, such as Hours of Service for third party telematics service providers. The company’s products are used in and/or targeted to a range of mobile resource management industry sectors, including haulage and distribution, public transportation, construction, and public safety services. It primarily serves application service providers, and solution providers specializing in the mobile resource management markets in the United States, Israel, and internationally. The company was formerly known as Micronet Enertec Technologies, Inc. and changed its name to MICT, Inc. in July 2018. MICT, Inc. was founded in 2002 and is headquartered in Montvale, New Jersey.

Future Farm

Private Placement in 2018
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

NioCorp

Post in 2022
NioCorp Developments Ltd. explores for and develops mineral deposits in North America. It owns and develops the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. The company was formerly known as Quantum Rare Earth Developments Corp. and changed its name to NioCorp Developments Ltd. in March 2013. NioCorp Developments Ltd. was incorporated in 1987 and is headquartered in Centennial, Colorado.

US Nuclear

Private Placement in 2019
US Nuclear Corp is a holding company specializing in the development and manufacturing of radiation detection instrumentation through three operating divisions (Technical Associates (TA), Overhoff Technology (OTC), and Electronic Control Concepts (ECC). The company supplies radiation detection instruments to nuclear power plants, national laboratories, government agencies, homeland security, military, universities and schools, research companies, hospitals, energy companies, weapons facilities, first responders, local governments, and individuals. The DroneSensor system uses state-of-the-art industrial-grade drones carrying radiation and chemical sensors. Wireless transmission to the ground station provides real-time data. By integrating and mounting radiation, chemical sensors, and biohazard samplers on drone platforms are providing a needed service to a variety of industries including air quality, oil and gas field safety, the mining industry, etc. US Nuclear was established in 1946 and is based in Canoga Park, California.

Future Farm

Private Placement in 2018
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

CytoTools

Private Placement in 2018
CytoTools AG is a biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms.

Allon Therapeutics

Post in 2010
Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. is headquartered in Vancouver, Canada.

Generation Alpha, Inc. (OTCPK:GNAL)

Private Placement in 2020
Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting and related equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lightning controller, a temperature monitoring control system; reflectors; and high intensity ng accessories, as well as plant nutrients and fertilizers. Its primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is headquartered in Upland, California.

CLS Holdings USA

Private Placement in 2018
CLS focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the marijuana plant and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories.

Hybrigenics

Post in 2009
Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.

Seedo Corp. (OTCPK:SEDO)

Private Placement in 2020
Seedo Corp. focuses on the development and distribution of home growing automated machines for various herbs and vegetables worldwide. It also develops herbs and vegetables commercial container. The company was founded in 2015 and is based in Yokneam Illit, Israel.

Q BioMed

Private Placement in 2019
Q BioMed Inc. 'Q' is a biomedical acceleration and development company. They are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need.

Medicago

Venture Round in 2010
Medicago Inc., a biotechnology company, focuses on the research, development, production, and commercialization of vaccines in Canada. The company develops its vaccines based on its proprietary technologies, including the plant-based Proficia technology and Virus-Like Particles (VLP) technology. Its product candidate includes H5N1 pandemic influenza VLP vaccine, which has completed a Phase I human clinical trial. The company is also developing H1N1 VLP vaccine for Influenza A/California/04/09 virus; and seasonal influenza vaccines. Medicago Inc. has collaboration agreements with Viridis S.A.; Genopole biopark to manufacture pandemic and seasonal influenza vaccines; and Philip Morris International to produce a therapeutic protein with a humancompatible glycosylation pattern. The company was incorporated in 1997 and is headquartered in Quebec City, Canada.

Amur Minerals

Private Placement in 2018
Amur Minerals Corporation, together with its subsidiaries, locates, evaluates, acquires, explores, and develops mineral properties and projects in the Far East of Russia. The company primarily explores for nickel, copper, cobalt, platinum, palladium, gold, and silver deposits. Its principal asset is the Kun-Manie nickel copper sulphide project that covers an area of 36 square kilometers located in Amur Oblast. The company was incorporated in 2004 and is based in Road Town, British Virgin Islands.

Future Farm

Private Placement in 2019
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

GECI International Group

Private Placement in 2017
GECI International Group, a specialist in innovation & technologies, assists major manufacturers, SMEs or start-ups in the new digital world of today. With its globally recognized credibility and ability to mobilize the most qualified skills, GECI International targets high growth and high value-added markets, particularly in the fields of engineering, computing, telecommunications, and smart products and services.

WILEX

Post in 2010
WILEX a biopharmaceutical company, develops drugs and diagnostic agents to detect cancer, treat malignant tumours, and prevent metastases. Its product line includes RENCAREX, a phase III substance for the treatment of non-metastatic renal cell cancer; REDECTANE, a phase III substance for the treatment of renal mass; and MESUPRON, a phase II substance for the treatment of pancreatic and breast cancer. The company's products also comprise the MEK inhibitor WX-554, which is under Phase I clinical trial; and the other oncology projects, including PI3K inhibitor WX-037 and three antibody programmes under preclinical development. It has a strategic alliance with UCB Pharma S.A. to develop preclinical oncology portfolio. The company was founded in 1997 and is headquartered in Munich, Germany.

Airborne Wireless Network

Private Placement in 2018
Airborne Wireless Network, a development stage company, focuses on developing, marketing, and licensing a fully-meshed high-speed broadband airborne wireless network by linking aircraft in flight. It focuses on developing Infinitus, a high-speed broadband airborne wireless network that would enable participating aircraft to act as an airborne repeater or router, sending and receiving broadband signals from one aircraft to another. It intends to sell broadband wireless bandwidth to the telecommunications companies and Internet service providers. The company was formerly known as Ample-Tee, Inc. and changed its name to Airborne Wireless Network in May 2016. Airborne Wireless Network was founded in 2011 and is headquartered in Simi Valley, California.

Magnegas Corp

Private Placement in 2019
Taronis Technologies owns a patented plasma arc technology that enable two end use applications for fuel generation and water decontamination.

Cybergun

Private Placement in 2017
Cybergun is in designing and distributing replica dummy weapons for video game aficionados, sport or outdoor shooting, and collectors.
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.

Q BioMed

Private Placement in 2018
Q BioMed Inc. 'Q' is a biomedical acceleration and development company. They are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need.

Future Farm

Private Placement in 2018
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

Cybergun

Private Placement in 2018
Cybergun is in designing and distributing replica dummy weapons for video game aficionados, sport or outdoor shooting, and collectors.

Q BioMed

Private Placement in 2020
Q BioMed Inc. 'Q' is a biomedical acceleration and development company. They are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need.

Resverlogix

Post in 2010
Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.

Curetis

Convertible Note in 2018
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.

NioCorp

Post in 2024
NioCorp Developments Ltd. explores for and develops mineral deposits in North America. It owns and develops the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. The company was formerly known as Quantum Rare Earth Developments Corp. and changed its name to NioCorp Developments Ltd. in March 2013. NioCorp Developments Ltd. was incorporated in 1987 and is headquartered in Centennial, Colorado.

Q BioMed

Post in 2018
Q BioMed Inc. 'Q' is a biomedical acceleration and development company. They are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need.

Cardio Diagnostics

Post in 2023
Cardio Diagnostics makes heart disease prevention and early detection more accessible, personalized, and precise. Cardio Diagnostics transforms heart disease prevention through ML/AI and DNA-based solutions. Founded in 2017, Cardio Diagnostics is based in Coralville, Iowa, United States.

Virgin Orbit

Post in 2022
Virgin Orbit focuses on dedicated launches of small satellites (smallsats). Virgin Orbit develops vehicles to fly private astronauts, research experiments, and satellites to space—democratizing access to space for the benefit of life on Earth.
Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the United States. It develops fibers using genetic engineering technologies for use in various target markets, including textile, specialty fiber, and technical textile industries. The company was founded in 2006 and is based in Ann Arbor, Michigan.

Wearable Devices

Post in 2024
Wearable Devices LTD develops and manufactures touch free wearable controller for digital devices under the brand name Mudra. The device allows interaction with augmented reality, virtual reality and mixed reality headsets. The company also develops software application to support its hardware. Wearable Devices LTD was founded in 2014 and is based in Kiryat Tivon, Israel.

Todos Medical

Private Placement in 2019
The Todos Medical team is a multidisciplinary group that includes experts in medicine, physics, biochemistry, digital signal processing, and electrical engineering. This unique combination of the sciences gives TBIA its competitive advantage and uniqueness. The company was founded in 2009 and based in Rehovot, HaMerkaz.
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products with more efficient and effective delivery solutions for the treatment of pain. Scilex Pharmaceuticals was founded in 2012 and is based in Malvern, Pennsylvania.

Virgin Orbit

Post in 2022
Virgin Orbit focuses on dedicated launches of small satellites (smallsats). Virgin Orbit develops vehicles to fly private astronauts, research experiments, and satellites to space—democratizing access to space for the benefit of life on Earth.

Xos Trucks

Post in 2022
Xos Trucks Inc. operates as a transportation lab making electric commercial vehicle fleets and battery-electric vehicle platforms. It helps commercial fleets transition from diesel to zero-emission electric delivery vehicles with the same performance but lower operating costs. The company also develops electrified armored cars. It delivers trucks to Texas and Illinois, with future customers in Michigan and New Jersey. Xos Trucks Inc. was formerly known as Thor Trucks and changed its name to Xos Trucks Inc. in April 2019. The company was founded in 2016 and is based in North Hollywood, California.

Curetis

Post in 2019
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the United States. It develops fibers using genetic engineering technologies for use in various target markets, including textile, specialty fiber, and technical textile industries. The company was founded in 2006 and is based in Ann Arbor, Michigan.

NLS Pharma

Post in 2021
NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.

Cantabio Pharmaceuticals

Private Placement in 2017
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from their research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the United States. It develops fibers using genetic engineering technologies for use in various target markets, including textile, specialty fiber, and technical textile industries. The company was founded in 2006 and is based in Ann Arbor, Michigan.

Cantabio Pharmaceuticals

Private Placement in 2018
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from their research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
Ashford Hospitality Trust, Inc., (Ashford) together with its subsidiaries, is a self-administered real estate investment trust (REIT) focused on investing in the hospitality industry. The Company owns its lodging investments and conducts its business through Ashford Hospitality Limited Partnership, its operating partnership. Ashford OP General Partner LLC, which is a wholly owned subsidiary of the Company, serves as the sole general partner of its operating partnership. It operates in two business segments within the hotel lodging industry: direct hotel investments and hotel financing. Direct hotel investments include owning hotels through either acquisition or new development. Hotel financing includes owning subordinate hotel-related mortgages through acquisition or origination. In August 2014, Ashford Hospitality Trust Inc acquired 357-room Fremont Marriott Silicon Valley hotel

D-Wave Systems

Post in 2022
D-Wave Systems designs and manufactures quantum computing and superconducting electronics. It offers D-Wave One system, a computing system that is designed for industrial problems encountered by Fortune 500 companies, government, and academia. The company also provides customer support, site preparation, site installation, training packages, and on-site engineer support services. D-Wave Systems was founded in 1999 and is based in Burnaby, Canada. The company has additional offices and R&D facilities in Palo Alto, California.

Future Farm

Post in 2018
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

VeriTeQ

Venture Round in 2009
VeriTeQ is a technology company focused on animal and emergency identification solutions. Its products are utilized around the world in such applications as pet identification using its patented, FDA-approved implantable microchip; livestock identification and tracking using visual and radio frequency identification (RFID) ear tags; and global positioning systems (GPS) search and rescue beacons for use on aircraft, ships and boats, and by adventure enthusiasts. The company was founded in 1993 and headquartered in Delray Beach, Florida.

Generation Alpha, Inc. (OTCPK:GNAL)

Private Placement in 2019
Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting and related equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lightning controller, a temperature monitoring control system; reflectors; and high intensity ng accessories, as well as plant nutrients and fertilizers. Its primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is headquartered in Upland, California.

Bit Origin

Private Placement in 2019
China Xiangtai Food Co., Ltd., through its subsidiaries, engages in the slaughtering, processing, packing, distribution, wholesale, and retail of various fresh pork meat and parts in the People’s Republic of China. It offers fresh pork and byproducts, as well as beef, lamb, chicken, duck, and rabbit meat. The company also provides sausage, bacon, canned meat, and sliced and ground pork. China Xiangtai Food Co., Ltd. was incorporated in 2018 and is headquartered in Chongqing, the People’s Republic of China.

MOI INC

Seed Round in 2017
The largest taxi cab company doesn’t own a single car, the largest hotel has no real estate and the biggest restaurateur doesn’t run a single kitchen. MOI aims to be the largest “Spa/Salon”, “Barbershops” “Beauty” providers in the world without any rent, employees nor overhead. OpenTable & Grubhub Combined for the Beauty Industry; Browse, Book, Pay and Rate with the Swipe of a finger.MOI is an app allowing to connect in one place all the qualified spas salons and barbershops as well as freelance qualified and vetted artists and consumers. MOI is an online booking aggregator of hair spa and beauty services that connects salons barbershops nail salons, etc... looking for customers with customers looking for grooming locations or at home services. MOI is about to launch in New York City in August 2017 . MOI is looking forward to launching in more cities in the coming year. MOI Inc. expects to launch its smart phone app allowing individuals to identify and book beauty services while conveniently identifying the specific services needed, whether it’s is a full service shaving, hair and makeup by either a professional coming to them, or at any salon or barbershops in any given geographical area, starting with NY Metro as our launching market with more than 18,000 salons and 2,000 barbershops. The “MOI” App is effortless to use, exciting and necessary. We aim to benefit both providers on the app, as well as our subscribers to become the “go – to” platform for beauty and grooming services. The company is currently only focusing on the New York market and intend to be the principal app for the entire industry. in addition the company has a (point of sale) POS that is given for free to all salons interested in having a highly efficient system, this is the only develloped by a cosmetologist Elana B, understandng the indsurty needs, the POS created is allowing to save money on receptionists and making them true hosts, as well as managing the calendar, inventory, employees, and synchronizing all for free with the app increasing bookings by 25% on average. MOI is an ambitious and advanced system taking into account (B2B needs) and B2C requirements, with qualified providers. the Only booking app rewarding exising loyal clients and exposing providers to new customers daily. MOI is an outlier of all the companies out there because it was created and envisioned by an insider to the industry Elana B, contrary to all the other platform that are created by individuals that do not understand the needs of the providers and their relationships to their customers.Nor really understand that clients need taillored services and obejctive reviews.

TowerJazz

Post in 2009
Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM), its fully owned U.S. subsidiary Jazz Semiconductor Inc., and its fully owned Japanese subsidiary TowerJazz Japan, Ltd., operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz manufactures integrated circuits, offering a broad range of customizable process technologies including: SiGe, BiCMOS, Mixed-Signal/CMOS, RFCMOS, CMOS Image Sensor, Power Management (BCD), and MEMS capabilities. TowerJazz also provides a world-class design enablement platform that enables a quick and accurate design cycle. In addition, TowerJazz provides (TOPS) Technology Optimization Process Services to IDMs and fabless companies that need to expand capacity. TowerJazz offers multi-fab sourcing with two manufacturing facilities in Israel, one in the U.S., and one in Japan.

Archos

Private Placement in 2018
Archos S.A. manufactures and sells consumer electronics worldwide. The company offers tablets, smartphones, connected objects, electrical vehicles, and cryptocurrency hardware wallets, as well as customized products and engineering services. Its products have entertainment/content protection, home automation, navigation, energy monitoring, education, digital signage, automotive, and audio and video guide applications, as well as in the vertical markets, including professional and medical markets. Archos S.A. was founded in 1988 and is headquartered in Igny, France.

Panion Animal Health AB

Private Placement in 2018
Panion Animal Health AB, a life science company, focuses on the development and commercialization of gene therapy treatments for neurological and other chronic diseases in animals. It develops epilepsy products for dogs. The company was founded in 2015 and is based in Lund, Sweden. As of July 10, 2019, Panion Animal Health AB operates as a subsidiary of CombiGene AB (publ).

Uk Oil & Gas

Private Placement in 2019
UK Oil & Gas PLC operates as an oil and gas exploration and production company in the United Kingdom. The company holds direct and indirect interests in a portfolio of eight UK onshore exploration, appraisal, development, and production assets in the Weald and Purbeck-Wight basins of Southern England. Its assets cover approximately 792 gross square kilometers. The company was incorporated in 2004 and is based in London, the United Kingdom.

Cellnovo

Private Placement in 2019
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition. The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.

Delta Drone

Private Placement in 2016
Founded at the beginning of 2011, an association of 4 founders with multidisciplinary profiles. Delta Drone is a French company that has experienced phenomenal growth, thanks to the confidence of their customers and shareholders. Initially a manufacturer of UAV’s, Delta Drone is now quoted on the stock exchange, ensuring Research and Development, UAV training, data processing and manufacturing, operation and commercial deployment of UAV’s at the forefront of technology. Headquartered in Grenoble, of which the founders also orginate, the company is currently deployed on additional sites in Lyon, Paris, Toulouse and internationally through its subsidiaries. First in the French industry in its sector and a large company of civilian drones for global professionals, Delta Drone offers to its customers a complete solution of aerial analysis collecting the automated processing of acquired data. Their research teams and engineers work in tandem to provide data processing specific to each industry. Engaged in several federations and various companies, Delta Drone is active in the structuring and regulation of UAV’s. The infancy of this sector requires the establishment of safety regulations and refined communication to anticipate the possible abuses of UAV’s, often related to weapons of war or model aircraft. Delta Drone requires ethical and safety rules for UAV’s and collaborates with the DGAC to change regulations.

TxCell

Private Placement in 2016
TxCell, a spin off of Inserm (France's National Institute for Health and Medical Research) located in the technology park of Sophia Antipolis, near Nice in southern France, is developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technology platform based on the properties of Type 1 regulatory T lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II study in refractory Crohn's disease patients and has reported first positive results. The company plans to initiate a PhIIb study in the same patient population and bring a second product candidate into a PhI/II study in refractory rheumatoid arthritis patients.

Curetis

Private Placement in 2018
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.

Generation Alpha, Inc. (OTCPK:GNAL)

Private Placement in 2020
Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting and related equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lightning controller, a temperature monitoring control system; reflectors; and high intensity ng accessories, as well as plant nutrients and fertilizers. Its primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is headquartered in Upland, California.

Medivie Therapeutics

Seed Round in 2014
Medivie was established in England in 2012 by Anthony Lovat, the founder of the OPRO Group, together with Capital International. The OPRO Group is a British Company founded 18 years ago and is the world's leading manufacturer of customized dental protectors. OPRO conducts extensive research and development activities in the dental field. the company is run by Joshua Rurka

Future Farm

Private Placement in 2019
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.

Bit Origin

Private Placement in 2020
China Xiangtai Food Co., Ltd., through its subsidiaries, engages in the slaughtering, processing, packing, distribution, wholesale, and retail of various fresh pork meat and parts in the People’s Republic of China. It offers fresh pork and byproducts, as well as beef, lamb, chicken, duck, and rabbit meat. The company also provides sausage, bacon, canned meat, and sliced and ground pork. China Xiangtai Food Co., Ltd. was incorporated in 2018 and is headquartered in Chongqing, the People’s Republic of China.

Seedo Corp. (OTCPK:SEDO)

Private Placement in 2019
Seedo Corp. focuses on the development and distribution of home growing automated machines for various herbs and vegetables worldwide. It also develops herbs and vegetables commercial container. The company was founded in 2015 and is based in Yokneam Illit, Israel.

Faraday Future

Post in 2022
Faraday Future is a design and technology company developing global solutions that re-imagine transportation, content, and ownership. At Faraday Future, we believe that today’s cars do not meet today’s needs. Technological innovations, energy constraints, urban crowding, and demanding lifestyles have each contributed to a fundamental shift in our relationships with our cars.

Kinarus AG

Post in 2022
Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.